GlassScriptPhysician profile
Richard D Burns
NPI 1609995901
$1,647.86
in general payments reported to CMS, 2019-2025
19 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $559 · 2022: $188 · 2023: $243 · 2024: $525 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633 · Education: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.76 |
| Education | $267.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $407.28 | 2021-2025 | Erleada, Balversa, Akeega |
| Abbvie INC. | $250.97 | 2021-2025 | |
| Astellas Pharma US INC | $229.69 | 2021-2024 | Myrbetriq, Xtandi |
| Myovant Sciences INC. | $155.87 | 2021-2022 | |
| Pfizer INC. | $110.43 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $79.44 | 2021-2023 | Lynparza, Keytruda |
| Cumberland Pharmaceuticals, INC. | $74.47 | 2021-2025 | Caldolor |
| Novartis Pharmaceuticals Corporation | $53.73 | 2024-2025 | |
| Blue Earth Diagnostics | $42.98 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.86 | 2022-2024 | |
| Urovant Sciences INC | $34.93 | 2021-2022 | |
| Olympus America INC. | $33.35 | 2024 | Soltive |
| Sumitomo Pharma America, INC. | $29.56 | 2024 | Gemtesa |
| Accord Healthcare, INC. | $22.72 | 2023 | |
| Travere Therapeutics, INC. | $21.60 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $19.47 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $16.23 | 2023 | Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Coloplast Corp | $13.26 | 2022 | |
| Teleflex LLC | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.